^™middle.

Gathering signals...

Star Combo Pharma (ASX:S66) — Material Events

ASX:S66 · 3 articles in the last 12 months · 100% assessed

Click a band to jump to that tier

Major ≥90 Significant 75–89 Notable 50–74 Routine <50 Not assessed

Significant Score 75–89

2

Star Combo Pharma Doubles Profit, Declares Second Dividend, Eyes Capacity BoostMedium

Star Combo Pharma posts strong FY2025 profit, declares second dividend, and plans capacity expansion

26 Aug 2025 ·Financial Results ·85

Star Combo Pharma Drives 7% Revenue Growth with $5.3M Profit Boost in FY25Medium

Star Combo Pharma posts 7% revenue growth and $5.3M profit before tax in FY25, driven by OEM segment

26 Aug 2025 ·Preliminary Final Report ·75

Notable Score 50–74

1

Star Combo Pharma Navigates 23% Revenue Drop with 49% Profit Surge in H1 FY26Medium

Star Combo Pharma reports 23% revenue decline but 49% profit rise in H1 FY26; Austoyou retail closed

25 Feb 2026 ·Half Year Report ·60

Not Assessed Low Score, or missing data

0

No articles in this tier for the last 12 months.

Market Mentions 1 - appeared in market wrap coverage

These are market wrap articles where Star Combo Pharma (ASX:S66) was mentioned. They reflect broader market coverage, not company-specific announcements.

Healthcare Wrap - Week 9 (23 Feb -> 27 Feb) 2026